Publication|Articles|February 17, 2025
- Pharmaceutical Executive: February 2025
- Volume 45
- Issue 1
Pharmaceutical Executive: February 2025 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2025 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 1 year ago
At First Glanceabout 1 year ago
2025 Pipeline Report: The Edge of Greatness?about 1 year ago
Inclusive Marketing: Engaging with Purposeabout 1 year ago
The Shifting Pharmacy Landscape in 2025about 1 year ago
Navigating the EU’s Joint Clinical Assessmentabout 1 year ago
Biopharma Business Check: Financing Review and Outlookabout 1 year ago
AI: Hungry for PowerNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Key Factors Contributing to Uncertainty in Moderna's mRNA Vaccine Review
2
Vinay Prasad Out at CBER for Second Time in Under a Year
3
Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial
4
Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals
5